藥物晶型研究_第1頁
藥物晶型研究_第2頁
藥物晶型研究_第3頁
藥物晶型研究_第4頁
藥物晶型研究_第5頁
已閱讀5頁,還剩21頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)

文檔簡介

1、2020/7/24,藥物的多晶型研究,2020/7/24,提綱,什么是晶體,多晶型? 多晶型研究對藥物開發(fā)的重要性 如何篩選和選擇藥物的新晶型 多晶型的主要分析手段 晶型篩選實驗的經(jīng)驗分享-溶劑選擇,2020/7/24,Crystal A solid material whose constituent atoms,molecules, or ions are arranged in an orderly repeating pattern extending in all three spatial dimensions. Pharmaceutical crystals Most drugs

2、 are developed as crystalline Stability Processability IP protection,什么是晶體?,什么是多晶型?,Polymorphism is the ability of a solid material to exist in more than one form or crystal structure. Polymorphs Sold phase Same chemical composition Different molecular arrangements In practice, we are interested in

3、all the crystalline and amorphous phases for a chemical/pharmaceutical,2020/7/24,2020/7/24,2020/7/24,多晶型研究對藥物開發(fā)的重要性,2020/7/24,藥物多晶型研究的重要性,2020/7/24,2020/7/24,如何篩選和選擇藥物的新晶型,2020/7/24,2020/7/24,2020/7/24,晶型的化學(xué)和物理分析手段,2020/7/24,2020/7/24,2020/7/24,Experience sharing on polymorph screening solvent selec

4、tion,2020/7/24,The purpose of polymorph screening,For Innovator companies - select the optimal solid-state of API for development -study relevant polymorphs for IP protection For CRO companies based on the customers needs - to identify as many new polymorphs (include solvate / hydrate) and amorphous

5、 form as possible - or to find the most stable form,The method of polymorph screening,2020/7/24,crystallization,crystallization from solution (slurry, anti-solvent precipitation , Solvent-thermal heating/cooling Slow/fast precipitation from saturated solutions),recrystallization from a neat compound

6、 (thermal heating/cooling, grinding , and high pressure ),polymorph screening crystallization from solution,2020/7/24,degree of supersaturation and Temperature are considered as the driving force of crystallisation diverse solvents result in the discovery of more polymorphs,crystallization from solu

7、tion Solvent selection,2020/7/24,Slurry Anti-solvent precipitation Solvent-thermal heating/cooling experiments Slow/fast precipitation from saturated solutions method,crystallization from solution rational experimental design,2020/7/24,Limited resource How to find as many new polymorphs and amorphou

8、s form as possible API properties different solubility in the solvent poor solubility or good solubility Solvent properties Polarity-different sort of solvents (alcohols, ethers, ester etc.) Boiling point Freezing point Toxicity miscibility,?,2020/7/24,Slurry solvent selection,Make sure the sample i

9、s suspension solvent/mixed solvents solubility is poor,2020/7/24,Anti-solvent precipitation solvent selection,Prepare solvent good solubility,Anti-solvent selection,Poor solubility,polarity,miscibility,miscibility Water DMF Heptane ACN 1,4-Dioxane MTBE DMSO,Solvent-thermal heating/cooling experiment

10、s,2020/7/24,change temperature supersaturation good solubility Solvent selection solubility varies with the temperature freezing point of the solvent,Slow/fast precipitation from saturated solutions method,2020/7/24,Evaporate the solvent supersaturation Slow/fast rate of crystallization Solvent selection low boiling point,SummarySolvent selection,2020/7/24,key point of the met

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論